409 related articles for article (PubMed ID: 34238239)
21. Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: A single-center retrospective observational cohort study.
Nakashima K; Aoshima M; Nakashita T; Hara M; Otsuki A; Noma S; Misawa M; Otsuka Y; Motojima S
J Microbiol Immunol Infect; 2018 Dec; 51(6):810-820. PubMed ID: 28779879
[TBL] [Abstract][Full Text] [Related]
22. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.
Para MF; Finkelstein D; Becker S; Dohn M; Walawander A; Black JR
J Acquir Immune Defic Syndr; 2000 Aug; 24(4):337-43. PubMed ID: 11015150
[TBL] [Abstract][Full Text] [Related]
23. Pneumocystis carinii pneumonia prophylaxis and early clinical manifestations of severe perinatal human immunodeficiency virus type 1 infection. Northern California Pediatric HIV Consortium.
Maldonado YA; Araneta RG; Hersh AL
Pediatr Infect Dis J; 1998 May; 17(5):398-402. PubMed ID: 9613653
[TBL] [Abstract][Full Text] [Related]
24. The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study.
Singh R; Bemelman FJ; Hodiamont CJ; Idu MM; Ten Berge IJ; Geerlings SE
BMC Infect Dis; 2016 Feb; 16():90. PubMed ID: 26912326
[TBL] [Abstract][Full Text] [Related]
25. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials.
Prosty C; Katergi K; Sorin M; Rjeily MB; Butler-Laporte G; McDonald EG; Lee TC
Clin Microbiol Infect; 2024 Jul; 30(7):866-876. PubMed ID: 38583518
[TBL] [Abstract][Full Text] [Related]
27. [Pneumocystis pneumonia prophylaxis with low-dose trimethoprim/sulfamethoxazole during rituximab-containing chemotherapy].
Shimizu R; Sakemura R; Iwata S; Hayakawa H; Miyao K; Kajiguchi T
Rinsho Ketsueki; 2019; 60(5):365-371. PubMed ID: 31167996
[TBL] [Abstract][Full Text] [Related]
28. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.
Beumont MG; Graziani A; Ubel PA; MacGregor RR
Am J Med; 1996 Jun; 100(6):611-6. PubMed ID: 8678080
[TBL] [Abstract][Full Text] [Related]
29. An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for
Utsunomiya M; Dobashi H; Odani T; Saito K; Yokogawa N; Nagasaka K; Takenaka K; Soejima M; Sugihara T; Hagiyama H; Hirata S; Matsui K; Nonomura Y; Kondo M; Suzuki F; Nawata Y; Tomita M; Kihara M; Yokoyama-Kokuryo W; Hirano F; Yamazaki H; Sakai R; Nanki T; Koike R; Miyasaka N; Harigai M
Rheumatol Adv Pract; 2020; 4(2):rkaa029. PubMed ID: 33134810
[TBL] [Abstract][Full Text] [Related]
30. Trimethoprim-Sulfamethoxazole-associated early neutropenia in Mexican adults living with HIV: A cohort study.
Jacobo-Vargas TB; Báez-Saldaña R; Cruz-Hervert LP; Fortoul TI; Ahumada-Topete VH; Rodríguez-Ganén O; Vega-Barrientos RS
PLoS One; 2023; 18(5):e0285541. PubMed ID: 37167312
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of effectiveness, hyperkalaemia, and hepatotoxicity of trimethoprim-sulphamethoxazole prophylaxis for Pneumocystis jirovecii pneumonia in paediatric patients: A single-centre retrospective study.
Kato H; Hagihara M; Asai N; Mikamo H; Iwamoto T
Int J Antimicrob Agents; 2024 May; 63(5):107151. PubMed ID: 38508538
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
33. Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for
Awad M; Sierra CM; Mesghali E; Bahjri K
J Oncol Pharm Pract; 2021 Dec; 27(8):1936-1939. PubMed ID: 33307970
[TBL] [Abstract][Full Text] [Related]
34. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.
May T; Beuscart C; Reynes J; Marchou B; Leclercq P; Borsa Lebas F; Saba J; Micoud M; Mouton Y; Canton P
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):457-62. PubMed ID: 8158539
[TBL] [Abstract][Full Text] [Related]
35. Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer.
Caselli D; Petris MG; Rondelli R; Carraro F; Colombini A; Muggeo P; Ziino O; Melchionda F; Russo G; Pierani P; Soncini E; DeSantis R; Zanazzo G; Barone A; Cesaro S; Cellini M; Mura R; Milano GM; Meazza C; Cicalese MP; Tropia S; De Masi S; Castagnola E; Aricò M;
J Pediatr; 2014 Feb; 164(2):389-92.e1. PubMed ID: 24252793
[TBL] [Abstract][Full Text] [Related]
36. Altered trimethoprim-sulfamethoxazole ratios for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii dual infections in rat model.
Brun-Pascaud M; Chau F; Garry L; Farinotti R; Derouin F; Girard PM
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):201-7. PubMed ID: 8898664
[TBL] [Abstract][Full Text] [Related]
37. Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study.
Katsuyama T; Saito K; Kubo S; Nawata M; Tanaka Y
Arthritis Res Ther; 2014 Feb; 16(1):R43. PubMed ID: 24495443
[TBL] [Abstract][Full Text] [Related]
38. Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population.
McLaughlin MM; Galal A; Richardson CL; Sutton SH; Barr VO; Patel N; Mitchell P; Stosor V
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28833985
[TBL] [Abstract][Full Text] [Related]
39. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.
Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO
Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice.
Lobo ML; Esteves F; de Sousa B; Cardoso F; Cushion MT; Antunes F; Matos O
PLoS One; 2013; 8(8):e70619. PubMed ID: 23940606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
